High serum YKL-40 level is associated with poor prognosis in patients with lung cancer

ÇİLEDAĞ A., Akin Kabalak P., ÇELİK G., Demir N., YÜKSEL C., Koycu G., ...More

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.66, no.4, pp.273-279, 2018 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 66 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.5578/tt.67319
  • Journal Name: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.273-279
  • Keywords: Lung cancer, chronic obstructive pulmonary disease, prognosis, YKL-40, BIOMARKER
  • Ankara University Affiliated: Yes

Abstract

Introduction: YKL-40 is a glycoprotein that plays role in inflammation and malignant processes. High serum YKL-40 levels are associated with short survive in cancer and chronic obstructive pulmonary disease (COPD) is another reason to increase it's level. However, limited knowledges are known in YKL-40 along with lung cancer and COPD.